^
Praxis Extended RAS Panel is a next-generation sequencing (NGS) kit assesses 12 codons in KRAS/NRAS to simultaneously determine the presence of 56 activating mutations. The Praxis Extended RAS Panel is used to aid in the identification of patients eligible for treatment with Vectibix. The panel is intended to be used on the MiSeqDx instrument. On-instrument Local Run Manager software helps create a sequencing run, monitor run status, and analyze the sequencing data. It then delivers an easy-to-interpret report to guide therapy decisions accurately and efficiently.
Cancer:
Colorectal Cancer
Gene:
KRAS (KRAS proto-oncogene GTPase), NRAS (Neuroblastoma RAS viral oncogene homolog)
Drug:
Vectibix (panitumumab)
Method:
Next-Generation Sequencing (NGS)
Approvals
Date
Cancer
Gene
Drug
By